Catalyst Pharmaceuticals (NASDAQ:CPRX) Upgraded at StockNews.com
StockNews.com upgraded shares of Catalyst Pharmaceuticals (NASDAQ:CPRX – Free Report) from a buy rating to a strong-buy rating in a research note issued to investors on Friday. Several other research firms have also recently commented on CPRX. Truist Financial upped their target price on shares of Catalyst Pharmaceuticals from $30.00 to $36.00 and gave the […]
StockNews.com upgraded shares of Catalyst Pharmaceuticals (NASDAQ:CPRX – Free Report) from a buy rating to a strong-buy rating in a research note issued to investors on Friday. Several other research firms have also recently commented on CPRX. Truist Financial upped their target price on shares of Catalyst Pharmaceuticals from $30.00 to $36.00 and gave the […]
